SCHEDULE OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS |
The
following table summarizes stock-based compensation recognized (within SG&A expenses) for fiscal years 2023 and 2022.
SCHEDULE
OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS
|
|
2023 |
|
|
2022 |
|
|
|
Year
Ended |
|
|
|
2023 |
|
|
2022 |
|
Employee Stock Options |
|
$ |
367,000 |
|
|
$ |
313,000 |
|
Director Stock Options |
|
|
181,000 |
|
|
|
95,000 |
|
Total |
|
$ |
548,000 |
|
|
$ |
408,000 |
|
|
SCHEDULE OF STOCK OPTIONS ROLL FORWARD |
The
summary of the Company’s total plans as of December 31, 2023, and 2022, and changes during the period then ended are presented
as follows:
SCHEDULE
OF STOCK OPTIONS ROLL FORWARD
|
|
Shares |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (years) |
|
|
Aggregate
Intrinsic Value (4) |
|
Options outstanding January 1, 2023 |
|
|
1,018,400 |
|
|
$ |
5.02 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
370,000 |
|
|
$ |
3.15 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(320,400 |
) |
|
$ |
3.72 |
|
|
|
|
|
|
$ |
2,335,042 |
|
Forfeited/expired |
|
|
(73,500 |
) |
|
$ |
3.77 |
|
|
|
|
|
|
|
|
|
Options outstanding end
of period (1) |
|
|
994,500 |
|
|
$ |
5.57 |
|
|
|
5.0 |
|
|
$ |
2,417,081 |
|
Options exercisable at
December 31, 2023(2) |
|
|
319,300 |
|
|
$ |
5.46 |
|
|
|
4.1 |
|
|
$ |
766,037 |
|
|
|
Shares |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (years) |
|
|
Aggregate
Intrinsic Value (4) |
|
Options outstanding January 1, 2022 |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
|
|
|
|
-
|
|
Granted |
|
|
94,000 |
|
|
$ |
5.20 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(52,400 |
) |
|
$ |
4.04 |
|
|
|
|
|
|
$ |
97,856 |
|
Forfeited/expired |
|
|
(42,600 |
) |
|
$ |
4.08 |
|
|
|
|
|
|
|
|
|
Options outstanding end
of period (3) |
|
|
1,018,400 |
|
|
$ |
5.02 |
|
|
|
3.8 |
|
|
$ |
44,262 |
|
Options exercisable at
December 31, 2022(3) |
|
|
530,900 |
|
|
$ |
4.27 |
|
|
|
2.4 |
|
|
$ |
30,962 |
|
(1) |
Options
with exercise prices ranging from $3.15 to $9.81 |
(2) |
Options
with exercise prices ranging from $3.15 to $7.50 |
(3) |
Options
with exercise prices ranging from $2.79 to $7.50 |
(4) |
The
intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price |
|
SCHEDULE OF NON VESTED OPTIONS |
The
summary of the Company’s nonvested options as of December 31, 2023, and changes during the period then ended are presented as follows:
SCHEDULE
OF NON VESTED OPTIONS
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
Grant-Date |
|
|
|
Shares |
|
|
Fair
Value |
|
Non-vested options January 1, 2023 |
|
|
487,500 |
|
|
$ |
3.32 |
|
Granted |
|
|
370,000 |
|
|
|
2.90 |
|
Vested |
|
|
(119,300 |
) |
|
|
3.27 |
|
Forfeited |
|
|
(63,000 |
) |
|
|
3.22 |
|
Non-vested options at December 31, 2023 |
|
|
675,200 |
|
|
$ |
3.12 |
|
|